GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » Revenue

Biogena Group Invest AG (WBO:BIO) Revenue : €0.17 Mil (TTM As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG Revenue?

Biogena Group Invest AG's revenue for the six months ended in Jan. 2024 was €0.17 Mil. Its revenue for the trailing twelve months (TTM) ended in Jan. 2024 was €0.17 Mil. Biogena Group Invest AG's Revenue per Share for the six months ended in Jan. 2024 was €0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2024 was €0.04.

Warning Sign:

Biogena Group Invest AG revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Biogena Group Invest AG was -33.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -36.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Biogena Group Invest AG's highest 3-Year average Revenue per Share Growth Rate was -36.60% per year. The lowest was -36.60% per year. And the median was -36.60% per year.


Biogena Group Invest AG Revenue Historical Data

The historical data trend for Biogena Group Invest AG's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG Revenue Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Revenue
0.33 0.33 0.25 0.17

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
Revenue 0.33 0.33 0.25 0.17

Competitive Comparison of Biogena Group Invest AG's Revenue

For the Packaged Foods subindustry, Biogena Group Invest AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Revenue distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's Revenue falls into.



Biogena Group Invest AG Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Revenue for the trailing twelve months (TTM) ended in Jan. 2024 was €0.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Biogena Group Invest AG Revenue Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.